000 04138naaaa2200889uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/69300
005 20220714185655.0
020 _abooks978-3-03943-490-9
020 _a9783039434893
020 _a9783039434909
024 7 _a10.3390/books978-3-03943-490-9
_cdoi
041 0 _aEnglish
042 _adc
072 7 _aM
_2bicssc
100 1 _aHirbe, Angela C.
_4edt
_91608912
700 1 _aPratilas, Christine A.
_4edt
_91608913
700 1 _aDodd, Rebecca D.
_4edt
_91608914
700 1 _aHirbe, Angela C.
_4oth
_91608912
700 1 _aPratilas, Christine A.
_4oth
_91608913
700 1 _aDodd, Rebecca D.
_4oth
_91608914
245 1 0 _aGenomics and Models of Nerve Sheath Tumors
260 _aBasel, Switzerland
_bMDPI - Multidisciplinary Digital Publishing Institute
_c2020
300 _a1 electronic resource (172 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aNerve sheath tumors can be a significant cause of morbidity for many patients. These include benign tumors such as schwannomas, diffuse and plexiform neurofibromas, and atypical neurofibromas, as well as the aggressive soft tissue sarcoma known as the malignant peripheral nerve sheath tumor (MPNST). Nerve sheath tumors occur sporadically and in the context of the clinical neuro-genetic tumor predisposition syndromes neurofibromatosis type 1 (NF1) and type 2 (NF2). Historically, the mainstay of treatment for nerve sheath tumors has been surgery. However, for both benign and malignant nerve sheath tumors, there is a high recurrence rate, highlighting the pressing need for novel therapies. As we have entered the genomic era, the hope is that an improved understanding of the genetics, and therefore the biology, of these tumors will ultimately lead to therapies that result in better outcomes. In this Special Issue, we include both review articles and original research related to the genomic understanding and modeling of schwannomas, plexiform and diffuse neurofibromas, atypical neurofibromas, and malignant peripheral nerve sheath tumors as well as genomic methods being developed and applied to advance our understanding of these tumors.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by/4.0/
_2cc
_4https://creativecommons.org/licenses/by/4.0/
546 _aEnglish
650 7 _aMedicine
_2bicssc
653 _aneurofibromatosis type 1
653 _anerve sheath tumor
653 _acancer
653 _alatent variables
653 _amachine learning
653 _asupervised learning
653 _atransfer learning
653 _arandom forest
653 _ametaVIPER
653 _atumor deconvolution
653 _aneurofibromatosis
653 _amalignant peripheral nerve sheath tumor
653 _aMPNST
653 _apolycomb repressive complex
653 _aPRC2
653 _aNF1
653 _akinase
653 _akinome adaptation
653 _akinome reprogramming
653 _aMET
653 _aMEK
653 _adoxorubicin
653 _acapmatinib
653 _atram
653 _agenomics
653 _atumor evolution
653 _apathology
653 _anext generation sequencing
653 _aclinical genetics
653 _amalignant peripheral nerve sheath tumors
653 _aplexiform neurofibromas
653 _aSchwann cells
653 _aneurofibromatosis type 1 syndrome
653 _aneurofibromin 1
653 _agenetically engineered mouse models
653 _aheterogeneity
653 _aCRISPR/Cas9
653 _amouse models
653 _asarcoma
653 _atumor microenvironment
653 _aneurofibromatosis 1 (NF1)
653 _amebendazole (MBZ)
653 _aCOX-2 inhibitor
653 _amalignancy
653 _achemoprevention
653 _anerve sheath tumors
856 4 0 _awww.oapen.org
_uhttps://mdpi.com/books/pdfview/book/3090
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/69300
_70
_zDOAB: description of the publication
999 _c3008914
_d3008914